Tongfu Qinghua Decoction Enema and Ruyi Jinhuang Powder for Acute Pancreatitis
NCT07712081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2026-07-17
Summary
Acute pancreatitis is an inflammatory condition that commonly causes abdominal pain, abdominal distension, impaired gastrointestinal function, and elevated pancreatic and inflammatory biomarkers. Although conventional medical treatment can stabilize most patients, recovery of gastrointestinal function and relief of local inflammation may remain slow.
This completed, single-center, randomized controlled study evaluated whether adding Tongfu Qinghua Decoction administered by enema and Ruyi Jinhuang Powder applied externally to conventional medical treatment could improve clinical recovery in adults with acute pancreatitis.
A total of 100 participants aged 18 to 75 years were randomly assigned in a 1:1 ratio to receive either conventional medical treatment alone or conventional medical treatment combined with Tongfu Qinghua Decoction enema and external application of Ruyi Jinhuang Powder. Both groups received treatment for 5 days.
The study evaluated overall clinical response, length of hospital stay, time to relief of abdominal pain and abdominal distension, recovery of bowel function, time to first food intake, serum and urinary amylase levels, C-reactive protein, procalcitonin, and treatment-related adverse events.
Conditions
Interventions
- DRUG
-
Tongfu Qinghua Decoction Enema
Tongfu Qinghua Decoction contained rhubarb 10 g, mirabilite 10 g, Magnolia officinalis bark 10 g, fried immature bitter orange 10 g, dandelion 30 g, Patrinia herb 30 g, Polygonum cuspidatum 30 g, honeysuckle 15 g, and Salvia miltiorrhiza 20 g. Prespecified syndrome-based modifications were permitted. The herbs were centrally decocted by the hospital pharmacy and concentrated to approximately 200 mL. The decoction was cooled to 38-40 degrees Celsius and administered slowly through a rectal tube inserted approximately 15-20 cm, with the participant in the left lateral position. Participants retained the solution for approximately 30 minutes. Treatment was administered once daily for up to 5 consecutive days and could be stopped earlier if symptoms resolved, spontaneous bowel movements occurred, or diarrhea developed.
- DRUG
-
Ruyi Jinhuang Powder External Application
Ruyi Jinhuang Powder, manufactured by Jiangsu 707 Natural Pharmaceutical Co., Ltd., was mixed with water or tea to form a paste and spread onto gauze. The prepared dressing was externally applied over the Shenque acupoint (CV8) and the surrounding area extending approximately 3-5 cm. The dressing was secured with adhesive tape and removed after approximately 4 hours. The intervention was administered twice daily for 5 consecutive days.
- OTHER
-
Conventional Medical Treatment
Conventional medical treatment for acute pancreatitis was provided according to the participant's clinical condition. Treatment included restriction of oral food and fluids when clinically required, gastrointestinal decompression, fluid resuscitation, nutritional support, inhibition of pancreatic secretion, and anti-infective treatment when indicated. Analgesic and antispasmodic medications were administered for symptomatic relief when necessary. The treatment course was 5 days.
Sponsors & Collaborators
-
The Third Affiliated Hospital of Wenzhou Medical University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-10-01
- Primary Completion
- 2025-08-30
- Completion
- 2025-09-01
Countries
- China
Study Locations
More Related Trials
-
Identification of the Impact of Acute Pancreatitis on Quality of Life
NCT04222075 ·Status: UNKNOWN
-
The Natural History of Chronic Pancreatitis
NCT03324698 ·Status: ACTIVE_NOT_RECRUITING
-
Thoracic Epidural Analgesia for Acute Pancreatitis With Early Organ Dysfunction
NCT07697690 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Risk Factors of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin
NCT02709421 ·Status: COMPLETED
-
Endotherapy for Painless Chronic Pancreatitis
NCT05261997 ·Status: UNKNOWN ·Phase: NA
-
Pancreatic Endotherapy for Refractory Chronic Pancreatitis
NCT04232670 ·Status: COMPLETED ·Phase: NA
-
The Efficacy of Pancreatic Duct Stenting With Rectal Indomethacin in Preventing Post-ERCP Pancreatitis
NCT03643900 ·Status: COMPLETED ·Phase: NA
-
Exercise Inhibit Innate Immune Response and Ameliorate Chronic Pancreatitis
NCT06534138 ·Status: COMPLETED
-
Optimal Timing of Endoscopic Intervention in the Treatment of Chronic Pancreatitis.
NCT05270434 ·Status: COMPLETED ·Phase: NA
-
Establishment of Clinical Staging of Chronic Pancreatitis Based on Histopathology of Pancreatic Duct Biopsy
NCT05352932 ·Status: UNKNOWN
-
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy
NCT05480241 ·Status: UNKNOWN ·Phase: NA
-
The Impact of Non-Alcoholic Fatty Pancreas Disease on Outcome of Acute Pancreatitis
NCT03394378 ·Status: COMPLETED
-
Risk Factors for Post-ESWL and Post-ERCP Pancreatitis
NCT04619511 ·Status: COMPLETED
-
Bowel Sound in Predicting the Severity of Acute Pancreatitis: Protocol of a Prospective, Multi-center Study
NCT06867120 ·Status: RECRUITING
-
Investigation on the Current Situation and Risk Factors Analysis of Exocrine Insufficiency in Chronic Pancreatitis
NCT06946108 ·Status: COMPLETED
-
Role of Antioxidants Supplementation in Chronic Pancreatitis
NCT00319358 ·Status: COMPLETED ·Phase: PHASE3
-
Establishment and Clinical Application of Pancreatic Endocrine and Exocrine Function Tests
NCT06006312 ·Status: UNKNOWN
-
Evidence Based Management of Acute Biliary Pancreatitis
NCT04615702 ·Status: COMPLETED
-
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
NCT07074379 ·Status: RECRUITING ·Phase: NA
-
Fecal Microbiota Transplantation (FMT) in Patients With Moderate to Severe Acute Pancreatitis
NCT07153809 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Effect of Bifidobacterium Longum in Patients with Acute Pancreatitis: a Randomized, Double-Blind, Placebo-Controlled Trial
NCT06639516 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Relation of Glucose and Acute Pancreatitis
NCT01470885 ·Status: COMPLETED
-
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
NCT05193162 ·Status: RECRUITING
-
Early Versus Standard Endoscopic Interventions for Peripancreatic Fluid Collections
NCT05281458 ·Status: UNKNOWN ·Phase: NA
-
Extracorporeal Shock Wave Lithotripsy and Endotherapy for Pain in Chronic Pancreatitis
NCT03966781 ·Status: COMPLETED ·Phase: NA